ZIVO Bioscience, Inc. Share Price Other OTC
Equities
ZIVO
US98978N1019
Food Processing
Sales 2024 * | 545K 43.63M | Sales 2025 * | 1.51M 121M | Capitalization | 22.7M 1.82B |
---|---|---|---|---|---|
Net income 2024 * | -8M -640M | Net income 2025 * | -8M -640M | EV / Sales 2024 * | 41.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 15.1 x |
P/E ratio 2024 * |
-2.93
x | P/E ratio 2025 * |
-3.68
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 59.42% |
Managers | Title | Age | Since |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 18/07/13 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 31/12/20 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 16/09/14 | |
Director/Board Member | 58 | 27/08/13 | |
John Payne
CEO | Chief Executive Officer | 76 | 18/07/13 |
1st Jan change | Capi. | |
---|---|---|
+8.20% | 7.78B | |
+0.34% | 7.38B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |